BCBS North Carolina Medical Policy Updates – February 2019

Click here to view the Blue Cross Blue Shield North Carolina Medical Policy Updates »

February 2019 Medical Policy Updates:

• Atezolizumab (Tecentriq) for Intravenous Use
• Bevacizumab in Advanced Adenocarcinoma of the Pancreas
• Bioimpedance Devices for Detection of Lymphedema
• CAR-T Therapy
• Daunorubicin and Cytarabine (Vyxeos)
• Edaravone (Radicava)
• Electrostimulation and Electromagnetic Therapy for Wounds
• Genetic Testing for FLT3, NPM1 and CEBPA Mutations in Acute Myeloid Leukemia
• Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia
• Hematopoietic Cell Transplantation for CLL and SLL
• Hematopoietic Cell Transplantation for Hodgkin Lymphoma
• Hematopoietic Stem-Cell Transplant For Non Hodgkin Lymphomas
• Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia
• Hematopoietic Stem-Cell Transplantation for Autoimmune Diseases
• Hematopoietic Stem-Cell Transplantation for CNS Embryonal Tumors and Ependymoma
• Hematopoietic Stem-Cell Transplantation for Epithelial Ovarian Cancer
• Hematopoietic Stem-Cell Transplantation for Miscellaneous Solid Tumors in Adults
• Intra Articular Hyaluronan Injections for Treatment of Osteoarthritis of the Knee
• Monoclonal Antibodies for Non-Hodgkin Lymphoma and Acute Myeloid Leukemia In the Non-Hematopoietic Stem Cell Transplant Setting
• Nerve Fiber Density Testing
• New-To-Market Specialty Drug PPA Requirements
• Non-Contact Ultrasound Treatment for Wounds
• Place of Service for Medical Infusions
• Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis
• Prostatic Urethral Lift
• Proteomic Testing for Targeted Therapy in Non-Small Cell Lung Cancer
• Quantitative Assay for Measurement of HER2 Total Protein Expression and HER2 Dimers
• Romiplostim (NPlate)
• Sphenopalatine Ganglion Block for Headache
• Surgery for Obstructive Sleep Apnea and Upper Airway Resistance Syndrome
• Surgical Treatment of Sinus Disease
• Urinary Tumor Markers for Bladder Cancer

Click here to view the Blue Cross Blue Shield North Carolina Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.